These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18775443)

  • 1. Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.
    Gjoni T; Urwyler S
    Neuropharmacology; 2008 Dec; 55(8):1293-9. PubMed ID: 18775443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
    Gjoni T; Urwyler S
    Eur J Pharmacol; 2009 Jan; 603(1-3):37-41. PubMed ID: 19109945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
    Urwyler S; Gjoni T; Koljatić J; Dupuis DS
    Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.
    Gjoni T; Desrayaud S; Imobersteg S; Urwyler S
    J Neurochem; 2006 Mar; 96(5):1416-22. PubMed ID: 16441514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
    Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
    J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.
    Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.
    Lhuillier L; Mombereau C; Cryan JF; Kaupmann K
    Neuropsychopharmacology; 2007 Feb; 32(2):388-98. PubMed ID: 16710312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
    Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GABA
    Olianas MC; Dedoni S; Onali P
    Eur J Pharmacol; 2017 Jan; 794():135-146. PubMed ID: 27876620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
    Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
    Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.
    Halbout B; Quarta D; Valerio E; Heidbreder CA; Hutcheson DM
    Addict Biol; 2011 Jul; 16(3):416-27. PubMed ID: 21309927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.
    Slattery DA; Markou A; Froestl W; Cryan JF
    Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
    Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
    Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro.
    Chen K; Li HZ; Ye N; Zhang J; Wang JJ
    Brain Res Bull; 2005 Oct; 67(4):310-8. PubMed ID: 16182939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice.
    Zemoura K; Ralvenius WT; Malherbe P; Benke D
    Neuropharmacology; 2016 Sep; 108():172-8. PubMed ID: 27108932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the neural circuits activated by a GABA
    Pizzo R; O'Leary OF; Cryan JF
    Neuropharmacology; 2018 Jul; 136(Pt A):129-145. PubMed ID: 28734870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model.
    Brown JW; Moeller A; Schmidt M; Turner SC; Nimmrich V; Ma J; Rueter LE; van der Kam E; Zhang M
    Neuropharmacology; 2016 Feb; 101():358-69. PubMed ID: 26471422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAB receptor transduction mechanisms, and cross-talk between protein kinases A and C, in GABAergic terminals synapsing onto neurons of the rat nucleus basalis of Meynert.
    Kubota H; Katsurabayashi S; Moorhouse AJ; Murakami N; Koga H; Akaike N
    J Physiol; 2003 Aug; 551(Pt 1):263-76. PubMed ID: 12815184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.